title: Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
authors.forename: G
authors.initials: G
authors.lastname: Liuzzi
authors.forename: M
authors.initials: M
authors.lastname: Zaccarelli
authors.forename: P
authors.initials: P
authors.lastname: Sette
authors.forename: S
authors.initials: S
authors.lastname: Grisetti
authors.forename: L
authors.initials: L
authors.lastname: Alba
authors.forename: A
authors.initials: A
authors.lastname: Antinori
mesh_terms: D000208:Acute Disease; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003075:Coitus; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006509:Hepatitis B / Q000635:transmission*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D015229:Sexually Transmitted Diseases, Viral / Q000635:transmission
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine